Pristiq (desvenlafaxine) Extended-Release Tablets 50 mg, 30 count bottle, Rx only, Distributed by Wyeth Pharmaceuticals, Inc., NDC 0008-1211-30

FDA recall notice · announced July 2, 2014 · Pfizer Us Pharmaceutical Group

Class II FDA/FSIS Class II: use may cause temporary or medically reversible adverse health consequences.

The product

Pristiq (desvenlafaxine) Extended-Release Tablets 50 mg, 30 count bottle, Rx only, Distributed by Wyeth Pharmaceuticals, Inc., NDC 0008-1211-30

Reason for recall

Presence of Foreign Tablets/Capsules: Pfizer is recalling 50 mg Pristiq (desvenlafaxine) extended release tablets because a single Pristiq 100 mg tablet was found in a bottle of 50 mg Pristiq.

Notes

Distribution: Nationwide
Lot/code information: H74477, H74478, Exp. 03/16, H74479, H79766 Exp. 05/16
Quantity: 220,761 bottles
Status: Terminated
Products in this recall event:
- Pristiq (desvenlafaxine) Extended-Release Tablets 50 mg, 30 count bottle, Rx only, Distributed by Wyeth Pharmaceuticals, Inc., NDC 0008-1211-30 (D-1409-2014)

Source: U.S. Food and Drug Administration public recall data. This page reports official records and is not legal, medical, or repair advice.